Bayer And Cadila Pool Products To Form Equal Stake JV For India Market
This article was originally published in PharmAsia News
MUMBAI - A deal that has been brewing for nearly two years has finally taken a concrete shape. Germany's Bayer Healthcare and India's Zydus Cadila have agreed to form an equal stake company that will see Bayer move its existing sales and marketing business in India to the new enterprise
You may also be interested in...
Bayer Challenges Nexavar Compulsory License To Natco; Says It Endangers Pharma Research
The German firm says challenges faced by the Indian healthcare system has little or nothing to do with patents
Bayer Expects Big Gains In APAC With Late-stage Pipeline And Zydus Cadila Joint Venture
Bayer expects half of its 43 clinical trials to be ready for the market in the next few years in Southeast Asia.
Bayer Lines Up Investments Worth €1.8 Billion To Expand In Asia
The German conglomerate targets doubling China and India sales by 2015